Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma

Wang,Xiaoying; Ju,Ying; Zhou,Mi; Liu,Xiaoli; Zhou,Chengjun

doi:10.3892/ol.2015.3303

Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma

Authors:
- Xiaoying Wang
- Ying Ju
- Mi Zhou
- Xiaoli Liu
- Chengjun Zhou
View Affiliations

Affiliations: Department of Pathology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
Published online on: June 2, 2015 https://doi.org/10.3892/ol.2015.3303
Pages: 990-994

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sex determining region Y‑box 9 (SOX9) is an important transcription factor in development and has been implicated in several types of cancer. Although the association between upregulation of SOX9 and lung adenocarcinoma (ADC) has been reported previously, the role of SOX9 in the proliferation, migration and invasion of cancer cells remains unclear. Therefore, in the present study, SOX9 expression was detected in 163 human lung adenocarcinoma tissues by immunohistochemistry and western blotting. It was found that the SOX9 protein was over‑expressed in the majority of lung adenocarcinoma. The full‑length human SOX9 plasmid was then transfected into the lung ADC A549 cell line. An MTT assay was used to investigate the role of SOX9 in cell proliferation. Scratch and extracellular matrix cell invasion assays were performed to investigate whether SOX9 promotes the migration and invasion of lung ADC cells. The results revealed that ectopic overexpression of SOX9 in the lung adenocarcinoma cell line resulted in a marked increase in cell proliferation, migration and invasion. Accordingly, knockdown of SOX9 by RNA interference resulted in the inhibition of cell growth, migration and invasion. The present data indicate that SOX9 may act as a novel marker for lung adenocarcinoma and perform an important role in cell proliferation, migration and invasion.

View Figures

View References

1	Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001. View Article : Google Scholar : PubMed/NCBI
2	Chen KY, Chang CH, Yu CJ, Kuo SH and Yang PC: Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Cancer. 103:2566–2574. 2005. View Article : Google Scholar : PubMed/NCBI
3	Yoshimi I, Ohshima A, Ajiki W, Tsukuma H and Sobue T: A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka cancer registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. Jpn J Clin Oncol. 33:98–104. 2003. View Article : Google Scholar : PubMed/NCBI
4	Toh CK and Lim WT: Lung cancer in never-smokers. J Clin Pathol. 60:337–340. 2007. View Article : Google Scholar : PubMed/NCBI
5	Liu NS, Spitz MR, Kemp BL, Cooksley C, Fossella FV, et al: Adenocarcinoma of the lung in young patients: The M. D. Anderson experience. Cancer. 88:1837–1841. 2000. View Article : Google Scholar : PubMed/NCBI
6	Chan BA and Hughes BG: Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future. Transl Lung Cancer Res. 4:36–54. 2015.PubMed/NCBI
7	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
8	Roh MS: Molecular pathology of lung cancer: Current status and future directions. Tuberc Respir Dis (Seoul). 77:49–54. 2014. View Article : Google Scholar : PubMed/NCBI
9	Wagner T, Wirth J, Meyer J, Zabel B, Held M, et al: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 79:1111–1120. 1994. View Article : Google Scholar : PubMed/NCBI
10	Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, et al: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature. 372:525–530. 1994. View Article : Google Scholar : PubMed/NCBI
11	Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, et al: Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res. 16:4363–4373. 2010. View Article : Google Scholar : PubMed/NCBI
12	Müller P, Crofts JD, Newman BS, Bridgewater LC, Lin CY, et al: SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res Treat. 120:317–326. 2010. View Article : Google Scholar : PubMed/NCBI
13	Lü B, Fang Y, Xu J, Wang L, Xu F, et al: Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 130:897–904. 2008. View Article : Google Scholar : PubMed/NCBI
14	Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, et al: SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 68:1625–1630. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zhou CH, Ye LP, Ye SX, et al: Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival. J Exp Clin Cancer Res. 31:182012. View Article : Google Scholar : PubMed/NCBI
16	Sirma H, Broemel M, Stumm L, Tsourlakis T, Steurer S, et al: Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 6:1245–1252. 2013.PubMed/NCBI
17	Südbeck P, Schmitz ML, Baeuerle PA and Scherer G: Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat Genet. 13:230–232. 1996. View Article : Google Scholar : PubMed/NCBI
18	Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N and German MS: Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci USA. 104:10500–10505. 2007. View Article : Google Scholar : PubMed/NCBI
19	Piper K, Ball SG, Keeling JW, Mansoor S, Wilson DI and Hanley NA: Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech Dev. 116:223–226. 2002. View Article : Google Scholar : PubMed/NCBI
20	Thomsen MK, Butler CM, Shen MM and Swain A: Sox9 is required for prostate development. Dev Biol. 316:302–311. 2008. View Article : Google Scholar : PubMed/NCBI
21	Wang H, McKnight NC, Zhang T, Lu ML, Balk SP and Yuan X: SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res. 67:528–536. 2007. View Article : Google Scholar : PubMed/NCBI
22	Blache P, van de Wetering M, Duluc I, Domon C, Berta P, et al: SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 166:37–47. 2004. View Article : Google Scholar : PubMed/NCBI
23	Passeron T, Valencia JC, Bertolotto C, Hoashi T, Le Pape E, et al: SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci USA. 104:13984–13989. 2007. View Article : Google Scholar : PubMed/NCBI